期刊文献+

蛋白酶抗性人睫状神经营养因子突变体基因的构建及其在巴斯德毕赤酵母中的表达 被引量:3

Construction of Protease Resistant Mutein of Human CNTF and Its Expression in Pichia pastoris
下载PDF
导出
摘要 AX15是一种比天然睫状神经营养因子具有更高的生物学活性、更好的稳定性和可溶性的hCNTF突变体。在巴斯德毕赤酵母中表达时AX15易发生降解。氨基酸序列分析表明降解位于由 12和 13位氨基酸残基组成的双碱性氨基酸之后。根据KEX2蛋白酶的底物专一性把双碱性氨基酸从RR变为RK ,构建了KEX2抗性的AX15突变体AX15 (R13K)。AX15 (R13K)的稳定性得到了显著的提高 ,在诱导 10 0h后也未发生降解。利用超滤浓缩和凝胶过滤得到了纯度 >90 %的AX15 (R13K)。TF 1细胞存活实验表明AX15 (R13K)具有与AX15相同的生物学活性。蛋白酶抗性人睫状神经营养因子突变体可能具有更好的体内稳定性 ,在临床应用上具有潜在的优势。 AX15 is a mutein of naturally occurring human ciliary neurophic factor (hCNTF), with improved biological activity, stability and solubility. AX15 is susceptible to protease degradation when expressed in Pichia pastoris. Amino acid sequencing revealed the degradation was occurred behind position 12 and 13 amino acid residues, which constitute a dibasic site, RR. Based on the substrate specificity of KEX2, a KEX2 resistant mutein of AX15-AX15(R13K) was constructed, in which RR was replaced by RK. It was demonstrated that the stability of AX15(R13K) improved significantly, as no degradation was detected even after 120 hours of induction. AX15(R13K) was purified to homogeneity by ultrafiltration and gel filtration. TF-1 cell survival bioassay showed AX15(R13K) had equivalent specific activity to AX15. The protease resistant mutein of AX15 may have greater in vivo stability and thus have superior therapeutic potential.
出处 《生物工程学报》 CAS CSCD 北大核心 2004年第3期394-397,共4页 Chinese Journal of Biotechnology
关键词 睫状神经营养因子 巴斯德毕赤酵母 蛋白酶抗性 ciliary neurophic factor, Pichia pastoris, protease resistant
  • 相关文献

参考文献13

  • 1Sleeman MW, Anderson KD, Lambert PD et al. The ciliary neurotrophic factor and its receptor, CNTFRα. Pharma Acta Helv, 2000,74(2) :265 - 272
  • 2Miller RG, Petajan JH, Bryan WW et al. A placedo-controlled trial of recombinant human ciliary neurotrophic factor (rhCNTF) in Amylotrophic Lateral Sclerosis. Ann Neurol, 1996,39(2):256-260
  • 3Lambert PD, Anderson KD, Sleeman MW et al. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci USA, 2001,98(8) :4652 -4657
  • 4Saggio I, Gloaguen I, Poiana G et al. CNTF variants with increased biological potency and receptor selectivity defined a function site of receptor interaction. The EMBO J, 1995,14(13) :3045 - 3054
  • 5Werten MWT, Bosch TTVD, Wind RD et al. High-yield secretion of recombinant gelatins by Pichia pastoris. Yeast, 1999,15(6): 1087 -1096
  • 6Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiology Review,2000,24( 1 ) :45 -66
  • 7Boehm T, Pirie SS, Trinh LB et al. Disruption of the KEX1 gene in Pichia pastoris allows expression of full-length murine and human endostatin. Yeast, 1999,15(3) :563 - 572
  • 8Deeley, Michael C, Price et al. DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues. United States Patent 5,391,485
  • 9Lin LFH, Armes LG, Sommert A et al. Isolation and characterization of ciliary neurotrophic factor from rabbit sciatic nerves. J Biol Chem,1990,265(15) :8942 - 8947
  • 10Jordan GL, Harcum SW. Characterization of up-regulated protease in an industrial recombinant Escherichia coli fermentation. J Ind Microb Biotech, 2002,28: 74 - 80

二级参考文献1

共引文献9

同被引文献36

  • 1刘彤,李晓东,王桂玲,李家滨,李丰.一种高效而经济获得长片段基因突变体的方法[J].生命科学研究,2006,10(1):34-38. 被引量:8
  • 2李招发,于学玲,黄金路,方宏清,陈惠鹏.重组巴曲酶在毕赤酵母中的高效表达[J].生物工程学报,2007,23(3):483-486. 被引量:8
  • 3Stocker K, Barlow G H. The coagulant enzyme from Bothrops atrox venom (Batroxobin) [M]. In: Lorand L. Methods in enzymology. New York.. Academic Press, 1976. 214-223.
  • 4Markland F S. Snake venoms and the hamostatic system[J]. Toxicon, 1998,36 : 1749-1800.
  • 5Weon-Kyoo You,Won-Seok Choi,You-Seok Koh,et a- 1. Functional characterization of recombinant batroxo- bin, a snake venom thrombin-like enzyme, expressedfrom Pichia pastoris[J]. FEBS Letters, 2004,571 : 67- 73.
  • 6Ho S, Horton R, Hunt H,et al. Site-directed mutagen- esis by overlap extension using the polymerase chain reaction[J]. Gene, 1989,77 (1) : 51-59.
  • 7Choi Kyu-Sil, Ghuman J, Kassam G, et al. Annexin Ⅱ Tetramer Inhibits Plasmin-Dependent Fibrinolysis[J]. Biochemistry, 1998,37(2) : 648-655.
  • 8Cook A L,Kirwin P M, Craig S, et al. Purification and analysis of protrinase-resistant mutants oI recombinant platelet-derived growth factor-BB exhibiting improved biological activity[J]. Biochem. J, 1992,281 : 57-65.
  • 9Schecter I,Berge A. On the size of the active site in proteases. I. Papain. Biochem. Biophys[J]. Res. Commun, 1967,27(2) : 157-162.
  • 10Rockwell N C,Wang G T,Krafft G A,et al. Internally consistent libraries of fluorogenic substrates demonstrate that Kex2 protease specificity is generated by multiple mechanisms[J]. Biochemistry, 1997,36 ( 7 ) : 1912-1917.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部